The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Reata Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:RETA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
14 Sep 23	SellUS$546,181	Andrea Loewen-Rodriguez	Individual	3,175	US$172.03
05 Sep 23	SellUS$68,695	Bhaskar Anand	Individual	406	US$169.20
16 Aug 23	SellUS$203,409	Dawn Bir	Individual	1,205	US$169.04
16 Aug 23	SellUS$463,052	Colin Meyer	Individual	2,740	US$169.07
16 Aug 23	SellUS$67,995	Bhaskar Anand	Individual	403	US$169.06
16 Aug 23	SellUS$203,581	Michael Wortley	Individual	1,205	US$169.04
16 Aug 23	SellUS$295,566	Manmeet Soni	Individual	1,755	US$168.41
14 Jun 23	SellUS$79,749	Bhaskar Anand	Individual	781	US$102.11
13 Jun 23	SellUS$5,983,414	Manmeet Soni	Individual	57,796	US$105.55
16 May 23	SellUS$109,829	Dawn Bir	Individual	1,311	US$85.09
16 May 23	SellUS$53,214	Samina Khan	Individual	640	US$85.32
16 May 23	SellUS$109,589	Michael Wortley	Individual	1,311	US$84.81
16 May 23	SellUS$527,063	Colin Meyer	Individual	6,233	US$85.77
16 May 23	SellUS$92,714	Bhaskar Anand	Individual	1,086	US$85.98
16 May 23	SellUS$1,869,150	Manmeet Soni	Individual	22,132	US$85.64
16 May 23	SellUS$616,352	Andrea Loewen-Rodriguez	Individual	7,166	US$86.26

Insider Buying: RETA insiders have only sold shares in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.4%.

Top 25 shareholders own 78.48% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12%	CPMG, Inc.	4,554,861	US$785.1m	0%	80.75%
7.41%	The Vanguard Group, Inc.	2,821,537	US$486.3m	2.57%	0.01%
6.72%	William Rose	2,559,011	US$441.1m	-19.4%	no data
6.66%	BlackRock, Inc.	2,538,770	US$437.6m	14.9%	0.01%
4.64%	Adage Capital Management, L.P.	1,766,070	US$304.4m	276%	0.67%
3.9%	Deutsche Asset & Wealth Management	1,486,467	US$256.2m	-0.56%	0.15%
3.86%	Wellington Management Group LLP	1,472,043	US$253.7m	3.58%	0.04%
3.85%	Dws Investment Gmbh	1,465,678	US$252.6m	0%	0.18%
3.76%	First Light Asset Management, LLC	1,432,208	US$246.9m	-9.75%	21.65%
3.75%	Tavistock Life Sciences	1,430,004	US$246.5m	16.3%	10.94%
2.76%	Janus Henderson Group plc	1,051,077	US$181.2m	371%	0.09%
1.87%	State Street Global Advisors, Inc.	713,150	US$122.9m	12.7%	0.01%
1.76%	Perceptive Advisors LLC	670,206	US$115.5m	-69.1%	3.81%
1.75%	Holocene Advisors, LP	667,950	US$115.1m	119%	0.53%
1.56%	Geode Capital Management, LLC	593,430	US$102.3m	8.03%	0.01%
1.5%	Emerald Advisers, LLC	572,483	US$98.7m	0.5%	2.66%
1.5%	Citadel Advisors LLC	571,529	US$98.5m	1,670%	0.13%
1.49%	Point72 Asset Management, L.P.	568,151	US$97.9m	42.4%	0.26%
1.46%	Millennium Management LLC	556,264	US$95.9m	160%	0.1%
1.31%	Radoff Family Foundation, Endowment Arm	500,000	US$86.2m	0%	95.11%
1.19%	Farallon Capital Management, L.L.C.	451,700	US$77.9m	39%	0.58%
1.07%	Fred Alger Management, LLC	407,170	US$70.2m	133%	0.37%
0.96%	Richard McGaughy	363,863	US$62.7m	0.41%	no data
0.9%	TimesSquare Capital Management, LLC	344,580	US$59.4m	10,000%	0.82%
0.89%	Blackstone Life Sciences	340,793	US$58.7m	0%	39.45%